International Immunopharmacology

International Immunopharmacology is a premier, peer-reviewed journal dedicated to the intersection of immunology and pharmacology, serving as a vital resource for researchers investigating the modulation of the immune system by chemical agents. Published by Elsevier, the journal’s scope encompasses the full spectrum of immunopharmacological research, from the molecular mechanisms of immune cell signaling to the preclinical and clinical development of immunomodulatory therapeutics. Core topics include the pharmacology of cytokines, chemokines, and growth factors; the immunological actions of natural products and traditional medicines; the development of vaccines and adjuvants; and the role of immune modulation in autoimmune diseases, inflammation, infectious diseases, and cancer. The journal welcomes original research articles, comprehensive reviews, short communications, and special issues focusing on emerging themes in the field. Its target audience includes immunologists, pharmacologists, medicinal chemists, and clinicians seeking to translate fundamental immune mechanisms into practical therapeutic strategies. A notable feature is its open access option, allowing authors to maximize the visibility and impact of their work. With an Impact Factor of 5.6000 for 2026 and a placement in the prestigious Q1 quartile of the JCR, International Immunopharmacology is firmly established as a high-tier publication. This standing reflects its consistent publication of rigorous, influential research that bridges basic science and clinical application, making it an essential journal for advancing the understanding and treatment of immune-mediated diseases.